CD44同型相互作用介导乳腺肿瘤细胞聚集与多克隆转移
在三阴性乳腺癌患者及代表性患者来源异种移植模型中,循环肿瘤细胞簇虽检出频率低于单个循环肿瘤细胞,但转移能力更强;活体多光子成像显示簇状肿瘤细胞源于单个细胞聚集而非集体迁移或 cohesive shedding。聚集细胞富集乳腺癌干细胞标志物CD44并促进肿瘤发生与多克隆转移,CD44耗竭可有效阻止细胞聚集并降低PAK2水平。
要点
- CD44同型相互作用介导肿瘤细胞多细胞聚集。
- CD44+循环肿瘤细胞簇与乳腺癌患者不良预后相关。
- CD44-PAK2互作激活FAK信号促进多克隆转移。
核心结论
- CD44+循环肿瘤细胞簇可作为多克隆转移的新治疗靶点。
研究设计与样本
- 研究采用三阴性乳腺癌患者样本及代表性患者来源异种移植模型。
- 使用活体多光子显微成像观察肿瘤细胞迁移与循环。
主要发现
- 循环肿瘤细胞簇检出频率低于单个循环肿瘤细胞但转移能力更强。
- 迁移和循环中的簇状肿瘤细胞源于单个肿瘤细胞聚集而非集体迁移和 cohesive shedding。
- 聚集肿瘤细胞富集乳腺癌干细胞标志物CD44并促进肿瘤发生和多克隆转移。
- CD44耗竭有效阻止肿瘤细胞聚集并降低PAK2水平。
- CD44-CD44同型相互作用需其N端结构域并启动CD44-PAK2互作以进一步激活FAK信号。
临床怎么用
- CD44+循环肿瘤细胞簇可作为预后预测的生物标志物。
- 靶向CD44同型相互作用或CD44-PAK2互作可能阻断多克隆转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Circulating tumor cells (CTC) seed cancer metastases; however, the underlying cellular and molecular mechanisms remain unclear. CTC clusters were less frequently detected but more metastatic than single CTCs of patients with triple-negative breast cancer and representative patient-derived xenograft models. Using intravital multiphoton microscopic imaging, we found that clustered tumor cells in migration and circulation resulted from aggregation of individual tumor cells rather than collective migration and cohesive shedding. Aggregated tumor cells exhibited enriched expression of the breast cancer stem cell marker CD44 and promoted tumorigenesis and polyclonal metastasis. Depletion of CD44 effectively prevented tumor cell aggregation and decreased PAK2 levels. The intercellular CD44-CD44 homophilic interactions directed multicellular aggregation, requiring its N-terminal domain, and initiated CD44-PAK2 interactions for further activation of FAK signaling. Our studies highlight that CD44+ CTC clusters, whose presence is correlated with a poor prognosis of patients with breast cancer, can serve as novel therapeutic targets of polyclonal metastasis. SIGNIFICANCE: CTCs not only serve as important biomarkers for liquid biopsies, but also mediate devastating metastases. CD44 homophilic interactions and subsequent CD44-PAK2 interactions mediate tumor cluster aggregation. This will lead to innovative biomarker applications to predict prognosis, facilitate development of new targeting strategies to block polyclonal metastasis, and improve clinical outcomes.See related commentary by Rodrigues and Vanharanta, p. 22.This article is highlighted in the In This Issue feature, p. 1.
引用
- Liu X, Taftaf R, Kawaguchi M, et al. Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. Cancer Discov. 2018. PMID: 30361447. doi:10.1158/2159-8290.CD-18-0065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。